Drug intelligence / Profile preview

Albumin iodinated I-125 serum

Development stage
Unknown
Lead developer
Mallinckrodt
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Albumin iodinated I-125 serum is a radiopharmaceutical diagnostic agent composed of human serum albumin labeled with the radioactive isotope iodine‑125. It is administered intravenously and used primarily for the determination of total blood and plasma volume, as well as measurement of circulation time and cardiac output. After injection, it distributes rapidly within the intravascular compartment, with slower movement into extravascular spaces. The mechanism relies on dilution principles using a known quantity of radiolabeled protein to calculate blood or plasma volume by measuring its distribution in the body. The drug is classified as a protein-based biologic therapy and functions solely as a diagnostic tool rather than having therapeutic effects[1][2][4][5][7]. Albumin iodinated I‑125 was originally developed by Mallinckrodt Medical and has been marketed under brand names such as Jeanatope[8]. It is currently manufactured by Iso-Tex Diagnostics[2][4][6].

Brand names
Jeanatope
Other names
iodinated I 125 albumin injectioniodine-125 human serum albuminiodine125 human serum albuminiodine 125 human serum albuminradioiodinated serum albumin (human)IHSA I 125

Beyond the preview

Go deeper on Albumin iodinated I-125 serum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Albumin iodinated I-125 serum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call